Categories AlphaGraphs, Earnings, Health Care
AMGN Earnings: Everything you need to know about Amgen’s Q2 results
Amgen Inc. (NASDAQ: AMGN) on Friday reported higher revenues and adjusted earnings for the second quarter of 2023. The biotechnology firm also provided guidance for fiscal 2023.
Adjusted earnings increased to $5.0 per share in the June quarter from $4.65 per share in the year-ago period. The reported net income was $1.38 billion or $2.57 per share in the latest quarter, compared to $1.32 billion or $2.45 per share in the same period of last year.
Total revenues increased 6% from last year to $6.98 billion during the three-month period. There was a 6% growth in product sales, benefiting from strong volume growth that was partially offset by 2% lower net selling price.
Prior Performance
Most Popular
Key highlights from Hasbro’s (HAS) Q1 2025 earnings results
Hasbro, Inc. (NASDAQ: HAS) reported its first quarter 2025 earnings results today. Revenue increased 17% year-over-year to $887.1 million. Net earnings attributable to Hasbro, Inc. were $98.6 million, or $0.70
MRK Earnings: Merck & Co. Q1 adj. profit rises, beats estimates
Merck & Co. Inc. (NYSE: MRK) Thursday reported an increase in adjusted earnings for the first quarter of 2025, while the pharma company's sales declined modestly. First-quarter sales were $15.5
PEP Earnings: All you need to know about PepsiCo’s Q1 2025 earnings results
PepsiCo, Inc. (NASDAQ: PEP) reported its first quarter 2025 earnings results today. Net revenue decreased 1.8% year-over-year to $17.9 billion. Organic revenue growth was 1.2%. Net income attributable to PepsiCo
